Cargando…
Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model
Lafora disease (LD) is a neurological disorder characterized by progressive myoclonus epilepsy. The hallmark of the disease is the presence of insoluble forms of glycogen (polyglucosan bodies, or PGBs) in the brain. The accumulation of PGBs is causative of the pathophysiological features of LD. Howe...
Autores principales: | Moreno-Estellés, Mireia, Campos-Rodríguez, Ángela, Rubio-Villena, Carla, Kumarasinghe, Lorena, Garcia-Gimeno, Maria Adelaida, Sanz, Pascual |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094345/ https://www.ncbi.nlm.nih.gov/pubmed/37046993 http://dx.doi.org/10.3390/ijms24076020 |
Ejemplares similares
-
Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan
por: Sullivan, Mitchell A., et al.
Publicado: (2017) -
Lafora Disease: A Ubiquitination-Related Pathology
por: García-Gimeno, Maria Adelaida, et al.
Publicado: (2018) -
AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models
por: Gumusgoz, Emrah, et al.
Publicado: (2022) -
Structure-Function Analysis of PPP1R3D, a Protein Phosphatase 1 Targeting Subunit, Reveals a Binding Motif for 14-3-3 Proteins which Regulates its Glycogenic Properties
por: Rubio-Villena, Carla, et al.
Publicado: (2015) -
An empirical pipeline for personalized diagnosis of Lafora disease mutations
por: Brewer, M. Kathryn, et al.
Publicado: (2021)